Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Alnylam Wins FDA Approval For Givlaari, Its Second RNAi Drug
Nov 20 2019
•
By
Jessica Merrill
Alnylam's Givlaari is the first drug approved for AHP
More from New Products
More from Scrip